arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Annexon, Inc.

ANNX
$3.98 ▼ -0.37 (-8.51%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
8 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

Annexon, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $617.3M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -102.2% ↘
FCF / Share $-1.20 ↘
Trailing P/E —
Price / Book 2.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-206.69M
↓ -49.6% —
FCF / Share Free cash flow per share
$-1.20
↓ -40.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
9
Cash Quality ↑
60

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 31 quarters